Merck acquires Imago BioSciences for $1.35 billion
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.
Swedish researchers have found a potential biomarker for severe Covid-19 disease that has claimed the lives of more than 6.5 million people globally.
About 45% of the world’s population, or 3.5 billion people, are suffering from oral diseases, a new study states.
WHO drafts an agreement for pharma companies to disclose contract terms for emergency vaccines
Antimalarial drug resistance in Africa is a severe cause for concern and parasite resistance to artemisinin medicine has emerged in the Greater Mekong.
Scientists have developed a vaccine against fentanyl addiction that works in rats and is ready for human trials
Mild Covid can reactivate latent viruses, especially in people suffering from chronic fatigue syndrome
Amazon announced it would set up virtual healthcare facilities in 32 states in the US for more than 20 health conditions and acquire.
Cough medications poisoning among children has risen in recent years
The Food and Drug Administration approved a new treatment for patients with advanced ovarian cancer — an antibody that delivers a targeted dose.